ArticleCritical public health2025
Exploring Black civil society perspectives of drug decriminalization reforms in the Baltimore context: a participatory action qualitative study.
Article in Critical public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Drug decriminalization is gaining recognition in academic and policy settings as an intervention to address the increasingly volatile drug crisis and achieve racially equitable drug policy reform in the United States. However, few studies elicit grassroots perspectives of Black communities most affected by legal change. This study explored the perspectives of Black civil society stakeholders on drug decriminalization to inform policy. From 2021 to 2022, racial justice policy advocates and university-based researchers conducted a participatory qualitative study, interviewing twelve key stakeholders a part of culturally responsive, Black-led efforts addressing drug-related harms at the grassroots level in Baltimore City, Maryland. A rapid qualitative analysis revealed that current decriminalization proposals overlook the structural harms of decades of drug criminalization and do not reflect the values that ground communities' responses to heal and become architects of the solution. Stakeholders recommended the incorporation of financial reparations and investment into a community-led support system that includes Black-owned businesses, harm reduction organizations, and psychospiritual care initiatives. For decriminalization to be effective in urban U.S. contexts, this study emphasizes the need for reforms to be community-led and inclusive of larger U.S. racial justice policy priorities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.